<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02293876</url>
  </required_header>
  <id_info>
    <org_study_id>ICU CORNEAL ULCER 01</org_study_id>
    <nct_id>NCT02293876</nct_id>
  </id_info>
  <brief_title>Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center</brief_title>
  <acronym>CORNEALPREV</acronym>
  <official_title>Risk for Corneal Injury in Critically Ill Patients and Effect of Nursing Interventions for Its Prevention: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Risoleta Tolentino Neves</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do estado de Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Risoleta Tolentino Neves</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is find out the better measure to achieve corneal protection in an
      Intensive Care Unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Critically ill patients are at higher risk for corneal injury and the mechanisms responsible
      for ocular lubrication and protection can be compromised. However, the literature diverges on
      which is the best clinical practice for treatment. There is a scale for assessing the risk
      for corneal injury. Thus, the general objective of this study was to evaluate the risk for
      developing corneal injury in critically ill patients and the effectiveness of three types of
      interventions: eye gel, eyedrops and polyethylene film, compared to the control group in its
      prevention. The specific objectives were: verify the most effective intervention for the
      prevention of corneal injury from the available literature and provided by: eye gel, eyedrops
      and polyethylene film compared to the control group who received eye care through randomized
      controlled clinical trial. Patients and methods: This study was a randomized controlled trial
      to determine the best care for the prevention of corneal injury from those available on the
      market (eye drops, eye gel and polyethylene film), compared to a control group (eye care) in
      the period from 09/07/2013 to 03/15/2014 .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Keratitis</measure>
    <time_frame>Five days</time_frame>
    <description>Presence of keratitis visible with a cobalt light ophthalmoscope and fluorescein eye drop.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Keratitis</condition>
  <condition>Corneal Ulcer</condition>
  <arm_group>
    <arm_group_label>Eye drop</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Eye drop LACRIBELL® - two drops each eye, three times a day, after eye cleansing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocular gel</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Ocular gel LIPOSIC® applied three times a day at the lower palpebra from medium line to the lateral border.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glad wrap</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Occlusion of the orbital area with a Glad wrap, turning the area into a moisture chamber.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Ocular cleansing three times a day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LACRIBELL®</intervention_name>
    <description>Hypromellose and dextran based eyedrop, used in the treatment of dry eye.</description>
    <arm_group_label>Eye drop</arm_group_label>
    <other_name>Eyedrop</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LIPOSIC®</intervention_name>
    <description>Carbomer and Sorbitol based gel, used in the treatment of dry eye.</description>
    <arm_group_label>Ocular gel</arm_group_label>
    <other_name>Occular Gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glad wrap</intervention_name>
    <description>A clear plastic wrap occluding eye and orbital area, turning the space into a moisture chamber.</description>
    <arm_group_label>Glad wrap</arm_group_label>
    <other_name>Polyethylene film</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ramsay sedation scale 5 or 6

          -  Glasgow coma scale lower than 7

          -  Use of oxygen therapy by facial device above 6 liters per minute or mechanical
             ventilation

          -  Blink reflex less than 5 times per minute or ocular globe exposure

        Exclusion Criteria:

          -  Less than 48 hours in Intensive Care Unit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>93 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreza Werli-Alvarenga, RN, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Risoleta Tolentino Neves</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Risoleta Tolentino Neves</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>31744012</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2014</study_first_posted>
  <last_update_submitted>November 18, 2014</last_update_submitted>
  <last_update_submitted_qc>November 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Risoleta Tolentino Neves</investigator_affiliation>
    <investigator_full_name>Andreza Werli Alvarenga</investigator_full_name>
    <investigator_title>RN, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Corneal Diseases</keyword>
  <keyword>Corneal Ulcer</keyword>
  <keyword>Nursing Diagnosis</keyword>
  <keyword>Intensive Care Units</keyword>
  <keyword>Nursing</keyword>
  <keyword>Randomized Clinical Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratitis</mesh_term>
    <mesh_term>Corneal Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

